Q4 2023 · 13F-HR
Ally Bridge Group (NY) LLCholdings as filed
Filed 2024-02-14 · accession 0000950123-24-002153
$167.8M
Reported value
22
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 471871103 | — | JASPER THERAPEUTICS INC | $28.9M | 17.2% | 3,659,255 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE - ADR | $13.3M | 7.93% | 35,000 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $12.5M | 7.43% | 309,950 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $11.6M | 6.90% | 489,938 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $11.1M | 6.64% | 241,961 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $10.1M | 6.03% | 141,348 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $9.2M | 5.51% | 659,035 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $9.0M | 5.35% | 150,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $8.7M | 5.16% | 143,479 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $8.0M | 4.78% | 100,862 | Common | SOLE |
| N5749R100 | 2GH | MERUS NV | $7.6M | 4.50% | 274,923 | Common | SOLE |
| 02083G100 | NVLSEUR | ALPINE IMMUNE SCIENCES INC | $6.8M | 4.06% | 357,271 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $6.3M | 3.74% | 2,971,639 | Common | SOLE |
| 641871108 | — | AMBRX BIOPHARMA INC | $5.5M | 3.27% | 385,383 | Common | SOLE |
| 05337M104 | — | AVADEL PHARMACEUTICALS-ADR | $4.9M | 2.92% | 347,036 | Common | SOLE |
| 41358P205 | HARPUSD | HARPOON THERAPEUTICS INC | $4.9M | 2.90% | 428,400 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $4.1M | 2.42% | 275,773 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $1.6M | 0.93% | 70,424 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $1.3M | 0.78% | 834,630 | Common | SOLE |
| 74346M406 | PMNEUR | PROMIS NEUROSCIENCES INC | $1.2M | 0.73% | 1,066,674 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $820,325 | 0.49% | 725,951 | Common | SOLE |
| 58406B202 | MDVLQ | MEDAVAIL HOLDINGS INC | $529,358 | 0.32% | 117,897 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.